Search for: "Sandoz GmbH" Results 41 - 60 of 68
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Sep 2011, 5:01 pm by Oliver G. Randl
In its interlocutory decision T 1068/07 of 25 June 2010, Board 3.3.08 referred the following question to the Enlarged Board of Appeal (EBA): Does a disclaimer infringe A 123(2) if its subject-matter was disclosed as an embodiment of the invention in the application as filed? [read post]
25 Feb 2011, 8:02 am by Steve Hall
The packaging indicated the drug was made by Sandoz International GmbH, a European generics company, Kentucky Justice and Public Safety Cabinet spokeswoman Jennifer Brislin said. [read post]
23 Feb 2011, 9:51 am by Steve Hall
The drug was made by Sandoz GmbH, an Austrian company, according to the Justice and Public Safety Cabinet. [read post]
3 Feb 2011, 8:39 am by Steve Hall
The shipments of thiopental entering the U.S. originated from an Austrian facility owned by Sandoz International GmbH, a German company, according to the complaint. [read post]
16 Sep 2010, 9:54 pm by Patent Docs
Foreign defendants Sandoz International GmbH and Novartis were... [read post]
7 May 2010, 11:11 am
Sulzer Morat GMBH, 139 F.3d 877, 881 (Fed. [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
25 Nov 2009, 3:00 am
(IP tango)   Canada OECD confirms Canada among lowest sources of counterfeiting (Michael Geist)   Chile Chilean wine does not escape piracy (IP tango)   China IP as loan collateral – another China innovation policy (China Hearsay) Look behind the headlines and China’s patent miracle is a lot easier to explain (IAM) Raising the bar of novelty – amended Patent Law (China Blawg) China patent series: Inventors and ownership (Maier & Maier)   Europe CFI: THINKING… [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
3 Apr 2009, 1:46 am
On Wednesday, while much of the IP world was amusing itself with April Fool pranks, the Court of Appeal (England and Wales) had more serious matters to resolve when it gave its decision in Napp Pharmaceutical Holdings Ltd v ratiopharm GmbH/Napp Pharmaceutical Holdings Ltd v Sandoz Ltd [2009] EWCA Civ 252. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]